Tesamorelin vs. CJC-1295 (no DAC) + Ipamorelin
A side-by-side reference for two research compounds. Comparison covers documented specifications only — no guidance on use is provided or implied.
How they differ
Tesamorelin
Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone studied in preclinical research on hypothalamic-pituitary signalling.
Published work has examined tesamorelin in models of GHRH-receptor activation and downstream endocrine signalling.
- GHRH-receptor signalling models
- Hypothalamic-pituitary axis research
- Peptide analogue stability studies
CJC-1295 (no DAC) + Ipamorelin
A combined preparation of CJC-1295 without DAC (modified GRF 1-29) and ipamorelin, a pentapeptide ghrelin-receptor ligand, supplied for in-vitro and preclinical signalling research.
The two components have each been examined in preclinical literature on GHRH-receptor and ghrelin-receptor signalling; the blend is supplied for studies of their combined receptor activity.
- GHRH-receptor and ghrelin-receptor signalling
- Combined secretagogue models in preclinical settings
- Receptor selectivity and binding research
Specification comparison
| Attribute | Tesamorelin | CJC-1295 (no DAC) + Ipamorelin |
|---|---|---|
| Research category | Muscle & Growth | Muscle & Growth |
| Price from | €54.00 | €74.00 |
| Availability | In stock | In stock |
Both compounds
Both are supplied for laboratory research use only.
Other comparisons
This comparison is a documentation reference only and does not describe or recommend any use of either compound.